Ray Dalio's Strategic Portfolio Adjustments in Q3 2024

Ray Dalio, the founder of Bridgewater Associates, has made significant portfolio adjustments in the third quarter of 2024, as revealed in his firm's latest 13F filing. Known for his strategic investment approach, Dalio added 79 new stocks to his portfolio, including major stakes in Micron Technology Inc, Alibaba Group Holding Ltd, and iShares MSCI Mexico ETF.

Dalio also increased his holdings in Lam Research Corp and Constellation Energy Corp, with significant percentage increases in share counts. However, he exited positions in The Walt Disney Co and Thermo Fisher Scientific Inc entirely.

A key move this quarter was the reduction of his stake in Procter & Gamble Co by 1,993,699 shares, a 55.46% decrease, impacting his portfolio by -1.72%. Similarly, his holdings in Johnson & Johnson were reduced by 1,734,184 shares, a 54.12% decrease, impacting the portfolio by -1.33%.

As of Q3 2024, Dalio's portfolio comprised 774 stocks, with top holdings in iShares Core S&P 500 ETF, iShares Core MSCI Emerging Markets ETF, Alphabet Inc, NVIDIA Corp, and SPDR S&P 500 ETF Trust. His portfolio spans 11 industries, including Technology, Consumer Cyclical, and Healthcare, reflecting a diversified strategy.

These strategic changes indicate Dalio's focus on adapting to macroeconomic trends and diversifying his investments across various sectors and geographies.